acetylcysteine has been researched along with rofecoxib in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Baum, Y; Hoffer, E; Nahir, AM | 1 |
| Ali, F; Birdsey, GM; Dumont, O; Evans, PC; Hamdulay, SS; Haskard, DO; Mason, JC; Wang, B; Wheeler-Jones, CP | 1 |
| Balbontín-Ayala, F; Cañigral, A; Carlos, Fd; Cobo, T; Fernández-González, FJ; Fernández-Vázquez, JP; Gonzalo-Orden, JM; Sánchez-Lasheras, F; Vega, JA | 1 |
1 review(s) available for acetylcysteine and rofecoxib
| Article | Year |
|---|---|
Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Bone Remodeling; Celecoxib; Clodronic Acid; Diclofenac; Diphosphonates; Humans; Imidazoles; Interferon-gamma; Isoxazoles; Lactones; Mice; Orthodontic Anchorage Procedures; Osteoclasts; Osteoprotegerin; Pamidronate; Rats; Resveratrol; Stilbenes; Sulfones; Tooth Mobility; Tooth Movement Techniques; Zoledronic Acid | 2015 |
3 other study(ies) available for acetylcysteine and rofecoxib
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
N-Acetylcysteine enhances the action of anti-inflammatory drugs as suppressors of prostaglandin production in monocytes.
Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dinoprostone; Drug Synergism; Expectorants; Humans; In Vitro Techniques; Lactones; Lipopolysaccharides; Monocytes; Sulfones | 2002 |
Celecoxib activates PI-3K/Akt and mitochondrial redox signaling to enhance heme oxygenase-1-mediated anti-inflammatory activity in vascular endothelium.
Topics: Acetylcysteine; Celecoxib; Chromones; Endothelial Cells; Enzyme Induction; Heme Oxygenase-1; Humans; Lactones; Morpholines; NF-E2-Related Factor 2; Oxidation-Reduction; Phosphatidylinositol 3-Kinases; Protein Transport; Proto-Oncogene Proteins c-akt; Protoporphyrins; Pyrazoles; Signal Transduction; Sulfonamides; Sulfones; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2010 |